365 related articles for article (PubMed ID: 30610793)
21. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2.
Yu D; Han GH; Zhao X; Liu X; Xue K; Wang D; Xu CB
Cell Oncol (Dordr); 2020 Apr; 43(2):249-261. PubMed ID: 31884576
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC.
Yang L; Li F; Lei F; Wang Y; Wu S; Song L; Chen Y
Tumour Biol; 2015 Sep; 36(10):7977-86. PubMed ID: 25964093
[TBL] [Abstract][Full Text] [Related]
24. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
[TBL] [Abstract][Full Text] [Related]
25. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
Feng X; Lv W; Wang S; He Q
Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
[TBL] [Abstract][Full Text] [Related]
26. Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study).
Yang Y; Zhou T; Chen X; Li J; Pan J; He X; Lin L; Shi YR; Feng W; Xiong J; Yang K; Yu Q; Zhang Q; Hu D; Sun Y; Hu G; Li P; Shen L; Lin Q; Zhang B; Qu X; Zou J; Zhang L; Fang W; Zhao Y
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34933967
[TBL] [Abstract][Full Text] [Related]
27. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
[TBL] [Abstract][Full Text] [Related]
28. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
[TBL] [Abstract][Full Text] [Related]
30. Expression and clinical significance of epidermal growth factor receptor and type 1 insulin-like growth factor receptor in nasopharyngeal carcinoma.
Yuan Y; Zhou X; Song J; Qiu X; Li J; Ye L; Meng X; Xia D
Ann Otol Rhinol Laryngol; 2008 Mar; 117(3):192-200. PubMed ID: 18444479
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
[TBL] [Abstract][Full Text] [Related]
32. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
33. CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis.
Tu Z; Chen Q; Zhang JT; Jiang X; Xia Y; Chan HC
Oncotarget; 2016 Nov; 7(47):76955-76965. PubMed ID: 27769067
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.
Liu Z; Li L; Yang Z; Luo W; Li X; Yang H; Yao K; Wu B; Fang W
BMC Cancer; 2010 Jun; 10():270. PubMed ID: 20534121
[TBL] [Abstract][Full Text] [Related]
35. MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
Wu SH; Han L; Lu BC; Wang HY; Zheng CP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2053-2061. PubMed ID: 30915749
[TBL] [Abstract][Full Text] [Related]
36. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
[TBL] [Abstract][Full Text] [Related]
37. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4.
Jiang C; Wang H; Zhou L; Jiang T; Xu Y; Xia L
Oncol Rep; 2017 Jul; 38(1):82-88. PubMed ID: 28504814
[TBL] [Abstract][Full Text] [Related]
39. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.
Liu LN; Huang PY; Lin ZR; Hu LJ; Liang JZ; Li MZ; Tang LQ; Zeng MS; Zhong Q; Zeng BH
J Transl Med; 2013 Jun; 11():140. PubMed ID: 23758975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
